Rethinking Idiopathic Pulmonary Fibrosis

Link to article at PubMed

Clin Chest Med. 2021 Jun;42(2):263-273. doi: 10.1016/j.ccm.2021.03.005.


Idiopathic pulmonary fibrosis (IPF) is a devastating disease for patients and their loved ones. Since initial efforts to characterize this disease in the 1960s, understanding of IPF has evolved considerably. Such evolution has continually challenged prior diagnostic and treatment paradigms, ushering in an era of higher confidence diagnoses with less invasive procedures and more effective treatments. This review details how research and clinical experience over the past half century have led to a rethinking of IPF. Here, the evolution in understanding of IPF pathogenesis, diagnostic evaluation and treatment approach is discussed.

PMID:34024402 | DOI:10.1016/j.ccm.2021.03.005

Leave a Reply

Your email address will not be published.